Marshall Wace »

Eupraxia Pharmaceuticals shares owned by Marshall Wace

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 158k 7.55

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Vivo Capital
Balyasny Asset Management
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Ikarian Capital
Royal Bank of Canada
Ally Bridge Group
Velan Capital Investment Management
Affinity Asset Advisors
Arrowstreet Capital, Limited Partnership
UBS Group
SummitTX Capital
Marshall Wace

View all funds holding Eupraxia Pharmaceuticals